3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Sleep Initiation and Maintenance Disorders
8
Anxiety Disorders
6
Neoplasms
5
Fatigue
4
Lymphoma
3
Depression
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Nervous System Diseases
2
Lymphoma, Follicular
2
Glioma
2
Weight Loss
1
Weight Gain
1
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Substance-Related Disorders
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Mental Disorders
1
Meningioma
1
Melanoma
1
Medication Adherence
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hepatitis B
1
Interventions
Temozolomide
18
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Radiotherapy
13
Radiation
9
Biopsy
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
Nivolumab
4
Bevacizumab
4
vorasidenib
3
trametinib
3
Surgical Procedures, Operative
3
Spinal Puncture
3
tovorafenib
2
dabrafenib
2
Restraint, Physical
2
Leukapheresis
2
Ipilimumab
2
Genetic Therapy
2
Fluorodeoxyglucose F18
2
Eflornithine
2
Craniotomy
2
Carboplatin
2
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
2
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Astrocytoma
×
Cognitive Behavioral Therapy
×
1 year
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled